Ibandronic Acid (IA)

[Edit]

Ibandronate Sodium

Ibandronic Acid (IA)
Ibandronate is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis. Ibandronate is indicated for the treatment and prevention of osteoporosis in post-menopausal women. Men should not take ibandronate unless they are participating in clinical trials. In May 2003, the U.S. Food and Drug Administration (FDA) approved Ibandronate as a daily treatment for post-menopausal osteoporosis. The basis for this approval was a three-year, randomized, double-blind, placebo-controlled trial women with post-menopausal osteoporosis. Every participant also received daily oral doses of calcium and 400IUs [international units] of vitamin D. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Ibandronic Acid (IA) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Ibandronic Acid (IA) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Ibandronic Acid (IA) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Ibandronic Acid (IA) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ibandronic Acid (IA) ELISA Kit Customized Service Offer